Eu Ivdd Eu Ivd General On The Market 🇨🇳 China

CORONAVIRUS [obsolete from 2025-01-01]

Devices (same UDI-DI)
1
Certificates
0
Countries
0
Notified Bodies
0

Basic Information

Primary DI
06930317801295
Basic UDI-DI Code
B-06930317801295
Reference
DNK-1419-1
Device Types
None provided
Regulation
Eu Ivdd
Classification
Eu Ivd General
Status
On The Market

Additional Description

The 2019-nCoV IgG/IgM Rapid Test is based on rapid immunochromatographic test. It is used for qualitative detection of 2019 Novel Coronavirus (also known as SARS-CoV-2) IgG and IgM antibody in human whole blood (Sodium citrate, EDTA, Sodium heparin) /serum/plasma (Sodium citrate, EDTA, Sodium heparin). The 2019-nCoV IgG/IgM Rapid Test is intended for use as an aid in identifying individuals with antibodies against SARS-CoV-2, indicating recent or prior infection. At this time, it is unknown for how long antibodies persist after infection and if the presence of antibodies confers protective immunity. The 2019-nCoV IgG/IgM Rapid Test should not be used to diagnose acute SARS-CoV-2 infection. Testing is limited to trained laboratory professionals use.

CND Nomenclature Codes

Code Description
W0105040619 CORONAVIRUS [obsolete from 2025-01-01]

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).

View all